めまいに対する治療効果判定の基準案(メニエール病を中心に) : 1993年めまいに対する治療効果判定基準化委員会答申  [in Japanese] Preliminary Guidelines for Reporting Treatment Results in Meniere's Disease According to Committee of Japan Society for Equilibrium Research  [in Japanese]

Access this Article

Search this Article

Author(s)

    • WATANABE Yukio
    • 富山医科薬科大学耳鼻咽喉科学教室 Department of Otolaryngology, Toyama Medical and Pharmaceutical University
    • SHOJAKU Hideo
    • 富山医科薬科大学耳鼻咽喉科学教室 Department of Otolaryngology, Toyama Medical and Pharmaceutical University

Abstract

In order to draft guidelines for reporting treatment results in Japan, the 17 Committee Members elected from the Japan Society for Equilibrium Research have held discussion for about two years. Preliminary guidelines are summarized here.<BR>1) Evaluation of Symptoms: Only definite vertiginous spells with spontaneous nystagmus should be considered for evaluation (AAOO 1972). Hearing levels assessed from the four-frequencies pure-tone average (PTA) at 250 Hz, 500 Hz, 1 KHz, 2 KHz in Meniere's disease.<BR>2) Evaluation Period: Valid results of the evaluation should be based on evalua-tion for over six months in pre-treatment and for more than twelve months in post-treatment after initiation of the therapy.<BR>3) Evaluation Criteria: The formula expressing the effects of treatment on ver-tiginous spells should be the same as the AAOHNS (1985) criteria. If the dura-tion of pre-treatment is less than six months, the divisor is the average number of definite spells per month during the period of observation.<BR>4) Global Judgment: Patients and doctors should evaluate on their treatment results from the standpoints of their subjective symptoms and objective signs, respectively.

Journal

  • Equilibrium Research

    Equilibrium Research 11, 80-85, 1995-04-01

    Japan Society for Equilibrium Research

References:  15

Cited by:  15

Codes

  • NII Article ID (NAID)
    10008728855
  • NII NACSIS-CAT ID (NCID)
    AN10382578
  • Text Lang
    JPN
  • Article Type
    Journal Article
  • ISSN
    09160337
  • Data Source
    CJP  CJPref  J-STAGE 
Page Top